Literature DB >> 19570999

The role of transposable elements in the regulation of IFN-lambda1 gene expression.

Scott J P Thomson1, Fui G Goh, Helen Banks, Thomas Krausgruber, Sergei V Kotenko, Brian M J Foxwell, Irina A Udalova.   

Abstract

IFNs lambda1, lambda2, and lambda3, or type III IFNs, are recently identified cytokines distantly related to type I IFNs. Despite an early evolutionary divergence, the 2 types of IFNs display similar antiviral activities, and both are produced primarily in dendritic cells. Although virus induction of the type I IFN-beta gene had served as a paradigm of gene regulation, relatively little is known about the regulation of IFN-lambda gene expression. Studies of virus induction of IFN-lambda1 identified an essential role of IFN regulatory factors (IRF) 3 and 7, which bind to a regulatory DNA sequence near the start site of transcription. Here, we report that the proximal promoter region of the IFN-lambda1 regulatory region is not sufficient for maximal gene induction in response to bacterial LPS, and we identify an essential cluster of homotypic NF-kappaB binding sites. Remarkably, these sites, which bind efficiently to NF-kappaB and function independently of the IRF3/7 binding sites, originate as transposable elements of the Alu and LTR families. We also show that depletion of the NF-kappaB RelA protein significantly reduces the level of the IFN-lambda1 gene expression. We conclude that IFN-lambda1 gene expression requires NF-kappaB, and we propose a model for IFN-lambda1 gene regulation, in which IRF and NF-kappaB activate gene expression independently via spatially separated promoter elements. These observations provide insights into the independent evolution of the IFN-lambda1 and IFN-beta promoters and directly implicate transposable elements in the regulation of the IFN-lambda1 gene by NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570999      PMCID: PMC2710658          DOI: 10.1073/pnas.0904477106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Genomes were forged by massive bombardments with retroelements and retrosequences.

Authors:  J Brosius
Journal:  Genetica       Date:  1999       Impact factor: 1.082

2.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

3.  Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes.

Authors:  Kerstin Wolk; Katrin Witte; Ellen Witte; Susanna Proesch; Gundula Schulze-Tanzil; Katarzyna Nasilowska; John Thilo; Khusru Asadullah; Wolfram Sterry; Hans-Dieter Volk; Robert Sabat
Journal:  J Leukoc Biol       Date:  2008-02-15       Impact factor: 4.962

4.  Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression.

Authors:  Effie Apostolou; Dimitris Thanos
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

5.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

6.  Evolution of a polymorphic regulatory element in interferon-gamma through transposition and mutation.

Authors:  Hans Ackerman; Irina Udalova; Jeremy Hull; Dominic Kwiatkowski
Journal:  Mol Biol Evol       Date:  2002-06       Impact factor: 16.240

Review 7.  Signaling pathways activated by interferons.

Authors:  L C Platanias; E N Fish
Journal:  Exp Hematol       Date:  1999-11       Impact factor: 3.084

8.  Genes, pseudogenes, and Alu sequence organization across human chromosomes 21 and 22.

Authors:  Chingfer Chen; Andrew J Gentles; Jerzy Jurka; Samuel Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

9.  IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.

Authors:  Caroline Sommereyns; Sophie Paul; Peter Staeheli; Thomas Michiels
Journal:  PLoS Pathog       Date:  2008-03-14       Impact factor: 6.823

10.  Two waves of nuclear factor kappaB recruitment to target promoters.

Authors:  S Saccani; S Pantano; G Natoli
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  59 in total

1.  Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.

Authors:  Jiali Fang; Qian Hao; Li Liu; Yongkui Li; Jianguo Wu; Xixiang Huo; Ying Zhu
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Genetics of IL28B and HCV--response to infection and treatment.

Authors:  C Nelson Hayes; Michio Imamura; Hiroshi Aikata; Kazuaki Chayama
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-29       Impact factor: 46.802

Review 3.  Evolutionary impact of transposable elements on genomic diversity and lineage-specific innovation in vertebrates.

Authors:  Ian A Warren; Magali Naville; Domitille Chalopin; Perrine Levin; Chloé Suzanne Berger; Delphine Galiana; Jean-Nicolas Volff
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

Review 4.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

5.  Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.

Authors:  Qingzhan Zhang; Hanzhong Ke; Anthony Blikslager; Takashi Fujita; Dongwan Yoo
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

Authors:  Charlotte Odendall; Andrew A Voak; Jonathan C Kagan
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

Review 7.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

8.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

9.  Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis.

Authors:  A Głobińska; M Pawełczyk; A Piechota-Polańczyk; A Olszewska-Ziąber; S Moskwa; A Mikołajczyk; A Jabłońska; P K Zakrzewski; M Brauncajs; M Jarzębska; S Taka; N G Papadopoulos; M L Kowalski
Journal:  Clin Exp Immunol       Date:  2016-11-14       Impact factor: 4.330

Review 10.  Functional impact of the human mobilome.

Authors:  Timothy D Babatz; Kathleen H Burns
Journal:  Curr Opin Genet Dev       Date:  2013-03-22       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.